Legal entity
All 1 tracked stories fall under one category: regulation. NHS is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are better corroborated than the beat average, carrying 4 original sources each against 3.3 for the same window.
Last mentioned: Jun 15, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: regulation. NHS is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are better corroborated than the beat average, carrying 4 original sources each against 3.3 for the same window. At 7, the average consequence score sits above the same-window beat average of 6.4. We currently track 1 Legal story that mention MHRA, all published on February 27, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 47 Legal stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering MHRA. Shared-story counts are live from our verified record — not editorial picks.
Target Implementation
Proposed date for the law to take full effect across the NHS and MHRA frameworks.
Committee Stage
Detailed line-by-line examination of the bill in the House of Commons.
Public Consultation
Opening of the consultation period for healthcare providers and biotech stakeholders.
Draft Bill Introduced
The UK Government unveils the draft Rare Cancers Law targeting incurable tumors.
The UK Government has introduced a landmark draft Rare Cancers Law designed to streamline regulatory pathways for incurable brain tumors and other orphan malignancies. This legislative shift aims to incentivize pharmaceutical R&D while providing patients with faster access to experimental therapies and clinical trials.
Source: yorkpress.co.uk · northwichguardian.co.uk
MHRA is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
